» Articles » PMID: 33597573

Spectrum of Mutational Signatures in T-cell Lymphoma Reveals a Key Role for UV Radiation in Cutaneous T-cell Lymphoma

Overview
Journal Sci Rep
Specialty Science
Date 2021 Feb 18
PMID 33597573
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell non-Hodgkin's lymphomas develop following transformation of tissue resident T-cells. We performed a meta-analysis of whole exome sequencing data from 403 patients with eight subtypes of T-cell non-Hodgkin's lymphoma to identify mutational signatures and associated recurrent gene mutations. Signature 1, indicative of age-related deamination, was prevalent across all T-cell lymphomas, reflecting the derivation of these malignancies from memory T-cells. Adult T-cell leukemia-lymphoma was specifically associated with signature 17, which was found to correlate with the IRF4 K59R mutation that is exclusive to Adult T-cell leukemia-lymphoma. Signature 7, implicating UV exposure was uniquely identified in cutaneous T-cell lymphoma (CTCL), contributing 52% of the mutational burden in mycosis fungoides and 23% in Sezary syndrome. Importantly this UV signature was observed in CD4 + T-cells isolated from the blood of Sezary syndrome patients suggesting extensive re-circulation of these T-cells through skin and blood. Analysis of non-Hodgkin's T-cell lymphoma cases submitted to the national 100,000 WGS project confirmed that signature 7 was only identified in CTCL strongly implicating UV radiation in the pathogenesis of cutaneous T-cell lymphoma.

Citing Articles

Phototherapy and mycosis fungoides: what's new?.

Iacovelli P, Pacifico A, Mariano M, Orsini D, DArino A, Pigliacelli F Dermatol Reports. 2024; 16(Suppl 2):9830.

PMID: 39295876 PMC: 11406204. DOI: 10.4081/dr.2023.9830.


Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma.

Witzig T, Sokol L, Kim W, de la Cruz Vicente F, Garcia-Sancho A, Advani R Blood Adv. 2024; 8(17):4581-4592.

PMID: 38991123 PMC: 11401221. DOI: 10.1182/bloodadvances.2024012806.


Vitamin D in Cutaneous T-Cell Lymphoma.

Odum A, Geisler C Cells. 2024; 13(6.

PMID: 38534347 PMC: 10969440. DOI: 10.3390/cells13060503.


Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Flechon L, Arib I, Dutta A, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R Blood Adv. 2024; 8(12):3109-3119.

PMID: 38513135 PMC: 11222946. DOI: 10.1182/bloodadvances.2023012125.


Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.

Gumina M, Hooper M, Zhou X, Koralov S J Invest Dermatol. 2023; 144(4):755-763.

PMID: 38149950 PMC: 10960716. DOI: 10.1016/j.jid.2023.10.023.


References
1.
Jiang L, Gu Z, Yan Z, Zhao X, Xie Y, Zhang Z . Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. Nat Genet. 2015; 47(9):1061-6. DOI: 10.1038/ng.3358. View

2.
Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y . Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014; 46(2):171-5. DOI: 10.1038/ng.2872. View

3.
Alexandrov L, Jones P, Wedge D, Sale J, Campbell P, Nik-Zainal S . Clock-like mutational processes in human somatic cells. Nat Genet. 2015; 47(12):1402-7. PMC: 4783858. DOI: 10.1038/ng.3441. View

4.
Sharma S, Grandvaux N, Mamane Y, Genin P, Azimi N, Waldmann T . Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J Immunol. 2002; 169(6):3120-30. DOI: 10.4049/jimmunol.169.6.3120. View

5.
Campbell J, Clark R, Watanabe R, Kupper T . Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010; 116(5):767-71. PMC: 2918332. DOI: 10.1182/blood-2009-11-251926. View